Involvement of calcium/calmodulin-dependent protein kinase II to endotoxin-induced vascular hyporeactivity in rat superior mesenteric artery

Pharmacological Research

Volumn 54, Issue 3, 2006, Pages 208-218

  Ozveren, E ^a   Korkmaz, B ^a   Buharalioglu, C K ^a   Tunctan, B ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Calcium calmodulin dependent protein kinase II; Cytosolic phospholipase A2 ; Endotoxin; Inducible cyclooxygenase; Inducible nitric oxide synthase; Rat mesenteric artery; Vascular hyporeactivity

Indexed keywords

CYCLOOXYGENASE 2; ENDOTOXIN; NITRIC OXIDE SYNTHASE; NORADRENALIN; PHENYLENEDIAMINE DERIVATIVE; PHOSPHOLIPASE A2; PHOSPHONIC ACID DERIVATIVE; PROTEIN KINASE (CALCIUM,CALMODULIN) II;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; AUTOOXIDATION; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUPERIOR MESENTERIC ARTERY; VASODILATATION;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 2 INHIBITORS; ENDOTOXINS; EPOPROSTENOL; MALE; MESENTERIC ARTERY, SUPERIOR; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; NOREPINEPHRINE; PHOSPHOLIPASES A; RATS; RATS, WISTAR;

EID: 33746363867     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.05.001     Document Type: Article

References (77)

1. Vila E., and Salaices M. Cytokines and vascular reactivity in resistance arteries. Am J Physiol 288 (2005) H1016-H1021
2. Briones A.M., Alonso M.J., Marin J., Balfagon G., and Salaices M. Influence of hypertension on nitric oxide synthase expression and vascular effects of lipopolysaccharide in rat mesenteric arteries. Br J Pharmacol 131 (2000) 185-194
3. Briones A.M., Alonso M.J., Hernanz R., Tovar S., Vila E., and Salaices M. Hypertension alters the participation of contractile prostanoids and superoxide anions in lipopolysaccharide effects on small mesenteric arteries. Life Sci 71 (2002) 1997-2014
4. Farmer M.R., Roberts R.E., Gardiner S.M., and Ralevic V. Effects of in vivo lipopolysaccharide infusion on vasoconstrictor function of rat isolated mesentery, kidney, and aorta. J Pharmacol Exp Ther 306 (2003) 538-545
5. Hernanz R., Alonso M.J., Zibrandtsen H., Alvarez Y., Salaices M., and Simonsen U. Measurements of nitric oxide concentration and hyporeactivity in rat superior mesenteric artery exposed to endotoxin. Cardiovasc Res 62 (2004) 202-211
6. MacKenzie A., and Wadsworth R.M. Extracellular l-arginine is required for optimal NO synthesis by eNOS and iNOS in the rat mesenteric artery wall. Br J Pharmacol 139 (2003) 1487-1497
7. Martinez M.C., Muller B., Stoclet J.C., and Andriantsitohaina R. Alteration by lipopolysaccharide of the relationship between intracellular calcium levels and contraction in rat mesenteric artery. Br J Pharmacol 118 (1996) 1218-1222
8. Mitolo-Chieppa D., Serio M., Potenza M.A., Montagnani M., Mansi G., Pece S., et al. Hyporeactivity of mesenteric vascular bed in endotoxin-treated rats. Eur J Pharmacol 309 (1996) 175-182
9. O'Brien A.J., Wilson A.J., Sibbald R., Singer M., and Clapp L.H. Temporal variation in endotoxin-induced vascular hyporeactivity in a rat mesenteric artery organ culture model. Br J Pharmacol 133 (2001) 351-360
10. O'Brien A.J., Thakur G., Buckley J.F., Singer M., and Clapp L.H. The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro. Br J Pharmacol 144 (2005) 367-375
11. Orliac M.L., Peroni R., Celuch S.M., and Adler-Graschinsky E. Potentiation of anandamide effects in mesenteric beds isolated from endotoxemic rats. J Pharmacol Exp Ther 304 (2003) 179-184
12. Piepot H.A., Groeneveld A.B., van Lambalgen A.A., and Sipkema P. The role of inducible nitric oxide synthase in lipopolysaccharide-mediated hyporeactivity to vasoconstrictors differs among isolated rat arteries. Clin Sci 102 (2002) 297-305
13. Schneider F., Schott C., Stoclet J.C., and Julou-Schaeffer G. l-arginine induces relaxation of small mesenteric arteries from endotoxin-treated rats. Eur J Pharmacol 211 (1992) 269-272
14. 2 on iNOS induction in rat mesenteric artery. Life Sci 66 (2000) 2173-2182
15. Yen M.H., Chen S.J., and Wu C.C. Role of endothelium-derived relaxing factor on vascular reactivity in endotoxin-induced shock. Chin J Physiol 36 (1993) 225-231
16. Klein S.M., Wong H.R., Dayao E.K., and Hauser G.J. Effect of tyrosine kinase inhibition on sepsis-induced vascular hyporesponsiveness, iNOS mRNA expression and NF-kappaB nuclear translocation in rats. Shock 14 (2000) 544-549
17. Wu C.C., Chen S.J., and Garland C.J. NO and KATP channels underlie endotoxin-induced smooth muscle hyperpolarization in rat mesenteric resistance arteries. Br J Pharmacol 142 (2004) 479-484
18. Fatehi-Hassanabad Z., Furman B.L., and Parratt J.R. The effect of endotoxin on sympathetic responses in the rat isolated perfused mesenteric bed; involvement of nitric oxide and cyclo-oxygenase products. Br J Pharmacol 116 (1995) 3316-3322
19. Mitchell J.A., Kohlhaas K.L., Sorrentino R., Warner T.D., Murad F., and Vane J.R. Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors. Br J Pharmacol 109 (1993) 265-270
20. Thiemermann C. The role of the l-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol 28 (1994) 45-79
21. 2. Biol Pharm Bull 27 (2004) 1168-1173
22. 2 enzymes. Prostaglandins Other Lipid Mediat 68-69 (2002) 3-58
23. Turini M.E., and DuBois R.N. Cyclooxygenase-2: a therapeutic target. Annu Rev Med 53 (2002) 35-57
24. 2 antagonist SQ29,548 impair in vitro contractions of aortic rings of ex vivo-treated lipopolysaccharide rats. J Lipid Mediat Cell Signal 13 (1996) 177-187
25. Fatehi-Hassanabad Z., Muller B., Andriantsitohaina R., Furman B.L., Parratt J.R., and Stoclet J.C. Influence of indomethacin on the haemodynamic effects of lipopolysaccharide in rats. Fundam Clin Pharmacol 10 (1996) 258-263
26. Gray G.A., Furman B.L., and Parratt J.R. Endotoxin-induced impairment of vascular reactivity in the pithed rat: role of arachidonic acid metabolites. Circ Shock 31 (1990) 395-406
27. 2 regulates vascular tone via its inhibitory effect on the expression of inducible nitric oxide synthase. Circulation 108 (2003) 2381-2386
28. Hamaguchi K., Kuwata H., Yoshihara K., Masuda S., Shimbara S., Oh-ishi S., et al. Induction of distinct sets of secretory phospholipase A(2) in rodents during inflammation. Biochim Biophys Acta 1635 (2003) 37-47
29. 2 in lung tissues in rats with endotoxic shock. Chin J Traumatol 7 (2004) 239-243
30. 2-independent mechanisms. Biochim Biophys Acta 1438 (1999) 213-222
31. 2. Cell Signal 14 (2002) 199-204
32. Levy R., Dana R., Hazan I., Levy I., Weber G., Smoliakov R., et al. Elevated cytosolic phospholipase A(2) expression and activity in human neutrophils during sepsis. Blood 95 (2000) 660-665
33. 2, arachidonyl trifluoromethyl ketone, attenuates LPS-induced lung injury in mice. Am J Physiol 284 (2003) L720-L726
34. Braun A.P., and Schulman H. The multifunctional calcium/calmodulin-dependent protein kinase: from form to function. Annu Rev Physiol 57 (1995) 417-445
35. Soderling T.R., Chang B., and Brickey D. Cellular signaling through multifunctional Ca2+/calmodulin-dependent protein kinase II. J Biol Chem 276 (2001) 3719-3722
36. Pfitzer G. Invited review: regulation of myosin phosphorylation in smooth muscle. J Appl Physiol 91 (2001) 497-503
37. Walsh M.P. Calmodulin and the regulation of smooth muscle contraction. Mol Cell Biochem 135 (1994) 21-41
38. 2+/calmodulin-dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of cultured rat aortic vascular smooth muscle cells. Circ Res 81 (1997) 575-584
39. 2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta. J Physiol 526 (2000) 367-374
40. Rokolya A., and Singer H.A. Inhibition of CaM kinase II activation and force maintenance by KN-93 in arterial smooth muscle. Am J Physiol Cell Physiol 278 (2000) C537-C545
41. Ignarro L.J., Fukuto J.M., Griscavage J.M., Rogers N.E., and Byrns R.E. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from l-arginine. Proc Natl Acad Sci USA 90 (1993) 8103-8107
42. 1 alpha in man. Biochim Biophys Acta 619 (1980) 207-213
43. Tunctan B., Ozveren E., Korkmaz B., and Buharalioglu C.K. Calcium/calmodulin dependent protein kinase II contributes to endotoxin-induced hyporeactivity via prostaglandin production in rat mesenteric artery. FASEB J 19 (2005) A1551
44. Mulvany M.J., and Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41 (1977) 19-26
45. Garvey E.P., Oplinger J.A., Tanoury G.J., Sherman P.A., Fowler M., Marshall S., et al. Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J Biol Chem 269 (1994) 26669-26676
46. 2 enzymes present in P388D1 macrophages. J Biol Chem 271 (1996) 6758-6765
47. 2 by methyl arachidonyl fluorophosphonate. Biochim Biophys Acta 1302 (1996) 55-60
48. Riendeau D., Percival M.D., Boyce S., Brideau C., Charleson S., Cromlish W., et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 121 (1997) 105-117
49. Tessier S., Karczewski P., Krause E.G., Pansard Y., Acar C., Lang-Lazdunski M., et al. Regulation of the transient outward K(+) current by Ca(2+)/calmodulin-dependent protein kinases II in human atrial myocytes. Circ Res 85 (1999) 810-819
50. Tunctan B., Altug S., Uludag O., Demirkay B., and Abacioglu N. Effects of cyclooxygenase inhibitors on nitric oxide production and survival in a mice model of sepsis. Pharmacol Res 48 (2003) 37-48
51. Mitsumizo S., Nakashima M., Hamada T., and Totoki T. NOS II inhibition restores attenuation of endothelium-dependent hyperpolarization in rat mesenteric artery exposed to lipopolysaccharide. J Cardiovasc Pharmacol 43 (2004) 589-594
52. Piepot H.A., Groeneveld A.B., van Lambalgen A.A., and Sipkema P. Endotoxin impairs endothelium-dependent vasodilation more in the coronary and renal arteries than in other arteries of the rat. J Surg Res 110 (2003) 413-418
53. Kilbourn R.G., and Belloni P. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 82 (1990) 772-776
54. Kleschyov A.L., Muller B., Schott C., and Stoclet J.C. Role of adventitial nitric oxide in vascular hyporeactivity induced by lipopolysaccharide in rat aorta. Br J Pharmacol 124 (1998) 623-626
55. Fleming I. Cytochrome p450 and vascular homeostasis. Circ Res 89 (2001) 753-762
56. Goodwin D.C., Landino L.M., and Marnett L.J. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis. FASEB J 13 (1999) 1121-1136
57. Roman J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82 (2002) 131-185
58. Amin A.R., Vyas P., Aattur M., Leszczynska-Piziak J., Patel I., Weissmann G., et al. The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci USA 92 (1997) 7926-7930
59. Habib A., Bernard C., Lebret M., Creminon C., Esposito B., Tedgui A., et al. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J Immunol 158 (1997) 3845-3851
60. Swierkosz T.A., Mitchell J.A., Warner T.D., Botting R.M., and Vane J.R. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 114 (1995) 1335-1342
61. Clancy R., Varenika B., Huang W., Ballou L., Attur M., Amin A.R., et al. Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol 165 (2000) 1582-1587
62. Boquet M., Cebral E., Motta A., Beron de Astrada M., and Gimeno M.A. Relationship between mouse uterine contractility, nitric oxide and prostaglandin production in early pregnancy. Prostaglandins Leukot Essent Fatty Acids 59 (1998) 163-167
63. Curtis J.F., Reddy N.G., Mason R.P., Kalyanaraman B., and Eling T.E. Nitric oxide: a prostaglandin H synthase 1 and 2 reducing cosubstrate that does not stimulate cyclooxygenase activity or prostaglandin H synthase expression in murine macrophages. Arch Biochem Biophys 335 (1996) 369-376
64. Hamilton L.C., and Warner T.D. Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: investigations using the selective inhibitors, 1400 W and celecoxib. Br J Pharmacol 125 (1998) 335-340
65. Rees D.D., Cellek S., Palmer R.M., and Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun 173 (1990) 541-547
66. 2 receptor subtype EP4 agonist attenuates cardiovascular depression in endotoxin shock by inhibiting inflammatory cytokines and nitric oxide production. Shock 22 (2004) 76-81
67. Guhring H., Hamza M., Sergejeva M., Ates M., Kotalla C.E., Ledent C., et al. Role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol 454 (2002) 153-163
68. 2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. Prostaglandins 49 (1995) 105-115
69. 2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. Circ Res 82 (1998) 204-209
70. 2 and other cyclic AMP stimulants in J774 macrophages. Biochem Pharmacol 53 (1997) 493-500
71. Tunctan B., Uludag O., Altug S., and Abacioglu N. Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice. Pharmacol Res 38 (1998) 405-411
72. 2 levels induced by lipopolysaccharide in mice. Biol Rhythm Res 31 (2000) 499-514
73. Tunctan B., Yaghini F.A., Estes A., and Malik K.U. Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production. FASEB J 18 (2004) A1034-A1035
74. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90 (1993) 7240-7244
75. 2+/calmodulin-dependent protein kinase II in endothelial NO production and endothelium-dependent relaxation. Am J Physiol 284 (2003) H2311-H2319
76. Liu S.F., Adcock I.M., Old R.W., Barnes P.J., and Evans T.W. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med 24 (1996) 1219-1225
77. Liu S.F., Newton R., Evans T.W., and Barnes P.J. Differential regulation of cyclo-oxygenase-1 and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat. Clin Sci 90 (1996) 301-306